Related Experiment Video
Updated: Jun 19, 2026

A Rabbit Venous Interposition Model Mimicking Revascularization Surgery using Vein Grafts to Assess Intimal Hyperplasia under Arterial Blood Pressure
Published on: May 15, 2020
Efficacy of aggressive lipid controlling therapy for preventing saphenous vein graft disease
Mitsumasa Hata1, Tadateru Takayama, Akira Sezai
1Department of Cardiovascular Surgery, Nihon University School of Medicine, Tokyo, Japan. mihata@med.nihon-u.ac.jp
Insights
Aggressive lipid controlling therapy (ALCT) significantly prevents saphenous vein graft disease after coronary bypass surgery. ALCT maintains low-density lipoprotein cholesterol below 80 mg/dL, avoiding plaque and thrombus formation in grafts.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Vascular Biology
Background:
- Coronary artery bypass grafting (CABG) using saphenous vein grafts (SVGs) is a common revascularization procedure.
- Saphenous vein graft disease (SVGD) remains a significant cause of graft failure and adverse cardiovascular events.
- Intracoronary imaging techniques are crucial for assessing SVG morphology and disease progression.
Purpose of the Study:
- To evaluate the efficacy of aggressive lipid-controlling therapy (ALCT) in preventing post-CABG SVG disease.
- To assess the impact of ALCT on lipid profiles and inflammatory markers in CABG patients.
- To investigate the presence of atherosclerotic plaques and thrombi in SVGs under different lipid management strategies.
Main Methods:
- A prospective study involving 21 patients post-CABG, divided into two groups based on lipid control.
- Group I (n=10) received rosuvastatin for ALCT (LDL-C < 80 mg/dL, LDL/HDL < 1.5).
- Group II (n=11) had uncontrolled hyperlipidemia (LDL-C > 100 mg/dL, LDL/HDL > 2.5) despite pravastatin.
- Intracoronary angioscopy and intravascular ultrasound (IVUS) were used to assess 27 SVGs 12-16 months post-CABG.
Main Results:
- Group I demonstrated significantly lower LDL-C (64.1 vs 130.2 mg/dL), LDL/HDL ratio (1.36 vs 2.64), and hs-CRP levels compared to Group II.
- IVUS revealed eccentric plaques in 78.6% of SVGs in Group II.
- Angioscopy showed yellow plaques in 100% and thrombi in 78.6% of SVGs in Group II, whereas Group I SVGs were free of these findings.
Conclusions:
- Aggressive lipid-controlling therapy is highly effective in preventing the development of atherosclerotic plaques and thrombi in SVGs post-CABG.
- Maintaining low LDL-C and LDL/HDL ratios is crucial for long-term SVG patency.
- Prophylactic management of lipid profiles is a promising strategy to avoid early and late SVG disease.
Background:
We assessed the efficacy of aggressive lipid controlling therapy (ALCT), which maintains low-density lipoprotein cholesterol (LDL-C) below to 80 mg/dL and LDL/high-density lipoprotein cholesterol (HDL-C) ratio less than 1.5 for preventing postcoronary bypass (CABG) saphenous vein graft (SVG) diseases by using intracoronary angioscopy.
Methods:
Twenty-one patients after CABG were divided into two groups: group I consisted of 10 patients whose serum LDL-C level and LDL/HDL could be controlled less than 80 mg/dL and 1.5, respectively, by rosuvastatin for about one year; group II consisted of 11 patients whose LDL-C level and LDL/HDL have been higher than 100 mg/dL and 2.5, respectively, regardless of having medication of pravastatin. Twenty-seven SVGs were assessed by intravascular ultrasound (IVUS) and angioscopy on postoperative 12 to 16 months.
Results:
The serum LDL-C level (I: 64.1 vs II: 130.2 mg/dL) and LDL/HDL (I: 1.36 vs II: 2.64), and high sensitive C-reactive protein (I: 0.045 +/- 0.100 vs II: 0.116 +/- 0.020 mg/dL) were significantly lower in group I. In group II, IVUS detected eccentric plaques in 11 (78.6%) of 14 SVGs. Furthermore the angioscope showed yellow plaque in all 14 SVGs (100%) and 11 (78.6%) of them had thrombi. On the other hand, in group I, all 13 SVGs had no eccentric, yellow plaques or thrombi and the intima was entirely clear white.
Conclusions:
Prophylactic treatment for yellow plaque and thrombus formation are extremely important in the development of early and late SVG disease. Aggressive lipid controlling therapy is quite attractive to avoid post CABG SVG disease and may be effective to maintain the long-term graft patency.
More Related Videos
09:04Synergizing Antegrade Endoscopic with Bridging Vein Harvesting for Improvement of Great Saphenous Vein Graft Quality from the Lower Leg
Published on: November 19, 2019
13:58A Rabbit Model of Durable Transgene Expression in Jugular Vein to Common Carotid Artery Interposition Grafts
Published on: September 10, 2018
Related Concept Videos
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Venous Thrombosis III: Interprofessional Care
Atherosclerosis III: Management
Peripheral Artery Disease III: Interprofessional Care
Venous Thrombosis IV: Nursing Management